ESR1 and breast carcinoma: Estrogen receptor (ER) positive breast cancer is considered to be a low risk form of the disease and anti-estrogen treatment is generally applied even though this disease can be recurrent, if not life-threatening (NCCN guidelines® http://www.nccn.org/).